Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Yi Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2720-0005; OpenAlex author ID A5013686582. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 11

  1. The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via mi… Co-author DOI 10.3389/fphar.2025.1613560↗
  2. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer. Co-author DOI 10.1002/jso.27582↗
  3. Circular RNAs in pancreatic cancer progression. Last author DOI 10.1016/j.cca.2023.117633↗
  4. Exosomal miRNAs in the microenvironment of pancreatic cancer. Co-author DOI 10.1016/j.cca.2023.117360↗
  5. Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis. Co-author DOI 10.1155/2022/3855462↗
  6. Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer. Co-author DOI 10.18632/aging.204080↗
  7. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. Co-author DOI 10.1172/jci.insight.129905↗
  8. Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathwa… Co-author DOI 10.18632/aging.103327↗
  9. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 … Co-author DOI 10.1016/j.bbrc.2018.12.088↗
  10. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis. Last author DOI 10.1016/j.gene.2018.03.048↗
  11. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.biopha.2017.08.124↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daolin Ji · 4 shared papers, 2020–2025 · strength 0.64
  2. Yunfu Cui · 4 shared papers, 2019–2023 · strength 0.57
  3. Gang Tan · 2 shared papers, 2022–2025 · strength 0.39
  4. Yue Yao · 3 shared papers, 2017–2019 · strength 0.31
  5. Jen Jen Yeh · 2 shared papers, 2020–2024 · strength 0.30
  6. Xiangyu Zhong · 2 shared papers, 2020–2023 · strength 0.29
  7. Chengru Yang · 1 shared paper, 2024 · strength 0.26
  8. Haolin Bao · 1 shared paper, 2024 · strength 0.26
  9. Wangyang Zheng · 2 shared papers, 2020–2022 · strength 0.25
  10. Sandra Zarmer · 1 shared paper, 2024 · strength 0.20
  11. Hannah E. Trembath · 1 shared paper, 2024 · strength 0.20
  12. Joseph F. Kearney · 1 shared paper, 2024 · strength 0.20
  13. Xinlei Zou · 1 shared paper, 2023 · strength 0.18
  14. Jianjun Gao · 1 shared paper, 2023 · strength 0.18
  15. Pengcheng Kang · 1 shared paper, 2020 · strength 0.11
  16. Matthew B. Lipner · 1 shared paper, 2020 · strength 0.09
  17. Gary L. Johnson · 1 shared paper, 2020 · strength 0.09
  18. Naim U. Rashid · 1 shared paper, 2020 · strength 0.09
  19. Richard A. Moffitt · 1 shared paper, 2020 · strength 0.09
  20. Lee M. Graves · 1 shared paper, 2020 · strength 0.09
  21. Cyrus Vaziri · 1 shared paper, 2020 · strength 0.09
  22. Yuehong Jiang · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.